Investor relations
Chris Davison
Head of Investor Relations
+44 20 7632 1000
Human resources
Caroline Carr
Chief Human Resources Officer
+44 20 7632 1000
Noémie de Andia
Head of Communications
+44 20 7632 1000
Denise Gallagher
Marketing Manager
+44 20 7632 1000
Permira Holdings Limited
Alistair Boyle
+44 1481 743200
Permira Debt Managers
James Greenwood
+44 2076321000


Past investment


At exit, PHARMAQ was one of the world’s leading aquatic health group manufacturing vaccines and therapeutic products for the aquaculture industry. See how our backing supported the company’s international growth and new product development plans…

Trade saleExit type
$765mExit value

Together we achieved

  • Strengthening of PHARMAQ’s position as a global leader in health products focused on the aquaculture industry
  • Expanding into emerging markets and becoming a viable alternative to antibiotics usage in food production, by launching the company’s first vaccines focused on pangasius in Vietnam and tilapia in Central America
  • Extending the product offering in the core salmonid market to provide protection against devastating diseases that are currently left unaddressed
  • Sale to a trade buyer


This was accomplished by

  • Partnering with the founding management team to make significant investments in strengthening the team to achieve the international growth agenda
  • Increasing R&D investment, allowing PHARMAQ to significantly expand and enhance its product offering for its core salmonid markets, as well as innovate new product lines catering to new species and geographies to better serve the rapidly developing aquaculture industry
  • Establishing dialogues with leading research institutions and regulatory bodies in key future growth markets ensuring PHARMAQ ready to capitalise on the opportunity from future industrialisation of aquaculture in emerging markets